Merck KGaA (OTCMKTS:MKKGY) Sets New 12-Month Low – Time to Sell?

Merck KGaA (OTCMKTS:MKKGYGet Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $28.96 and last traded at $29.08, with a volume of 139382 shares trading hands. The stock had previously closed at $29.31.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group assumed coverage on Merck KGaA in a research note on Thursday, September 19th. They issued a “buy” rating on the stock.

Get Our Latest Stock Analysis on Merck KGaA

Merck KGaA Price Performance

The firm has a market cap of $19.08 billion, a price-to-earnings ratio of 18.23, a price-to-earnings-growth ratio of 2.25 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock’s 50 day simple moving average is $33.63 and its 200-day simple moving average is $34.99.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Read More

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.